ArticleFrontiers in oncology2023

Identify and validate RUNX2 and LAMA2 as novel prognostic signatures and correlate with immune infiltrates in bladder cancer.

Yi Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.